Search research articles
Contact Us
Filters
Showing results (101-110 of 236) with videos related to
Page
of 24
Sort By:
Annals of Hematology
|
March 22, 2025
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival
Sara Oubari, Maria Papathanasiou, Lars Michel, et al.
Cancers
|
July 24, 2020
Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the <i>Eµ-TCL1</i> Transgenic Mouse Model
Maximilian Koch, Sebastian Reinartz, Julia Saggau, et al.
Blood Advances
|
October 27, 2020
Acute myeloid leukemia-induced remodeling of the human bone marrow niche predicts clinical outcome
Yiyang Chen, Lina Marie Hoffmeister, Yasmin Zaun, et al.
JACC. Advances
|
July 17, 2025
Safety and Feasibility of Transcatheter Edge-to-Edge Repair of Mitral Regurgitation in Cardiac Amyloidosis
Julia Vogel, Peter Luedike, Katharina Hellhammer, et al.
Blood Neoplasia
|
September 25, 2025
Eμ-TCL1 mice with conditional human BCL2 knockin as novel B-cell lymphoma model for studying venetoclax effects in vivo
Ismini Halmer, Daniela Asslaber, Laura Beckmann, et al.
Molecular Cell
|
October 12, 2010
DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization
H Christian Reinhardt, Pia Hasskamp, Ingolf Schmedding, et al.
Investigational New Drugs
|
November 11, 2019
A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer
Johanna C Bendell, Helge G Bischoff, Jimmy Hwang, et al.
The Journal of Cell Biology
|
May 11, 2011
NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway
Sandra Habbig, Malte P Bartram, Roman U Müller, et al.
Cancers
|
April 23, 2022
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma
Stephanie Kadow, Fabian Schumacher, Melanie Kramer, et al.
Transplantation and Cellular Therapy
|
March 9, 2025
Outcome of Patients With IDH-Mutated AML Following Allogeneic Stem Cell Transplantation-A Retrospective Analysis on Behalf of the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy, DRST
Thomas Schroeder, Sarah Flossdorf, Claudia Schuh, et al.
Page
of 24
Search research articles
Search
Showing results (101-110 of 236) with videos related to
Sort By:
Page
of 24
Annals of Hematology
|
March 22, 2025
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survival
Sara Oubari, Maria Papathanasiou, Lars Michel, et al.
Cancers
|
July 24, 2020
Meta-Analysis Reveals Significant Sex Differences in Chronic Lymphocytic Leukemia Progression in the <i>Eµ-TCL1</i> Transgenic Mouse Model
Maximilian Koch, Sebastian Reinartz, Julia Saggau, et al.
Blood Advances
|
October 27, 2020
Acute myeloid leukemia-induced remodeling of the human bone marrow niche predicts clinical outcome
Yiyang Chen, Lina Marie Hoffmeister, Yasmin Zaun, et al.
JACC. Advances
|
July 17, 2025
Safety and Feasibility of Transcatheter Edge-to-Edge Repair of Mitral Regurgitation in Cardiac Amyloidosis
Julia Vogel, Peter Luedike, Katharina Hellhammer, et al.
Blood Neoplasia
|
September 25, 2025
Eμ-TCL1 mice with conditional human BCL2 knockin as novel B-cell lymphoma model for studying venetoclax effects in vivo
Ismini Halmer, Daniela Asslaber, Laura Beckmann, et al.
Molecular Cell
|
October 12, 2010
DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization
H Christian Reinhardt, Pia Hasskamp, Ingolf Schmedding, et al.
Investigational New Drugs
|
November 11, 2019
A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer
Johanna C Bendell, Helge G Bischoff, Jimmy Hwang, et al.
The Journal of Cell Biology
|
May 11, 2011
NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway
Sandra Habbig, Malte P Bartram, Roman U Müller, et al.
Cancers
|
April 23, 2022
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple Myeloma
Stephanie Kadow, Fabian Schumacher, Melanie Kramer, et al.
Transplantation and Cellular Therapy
|
March 9, 2025
Outcome of Patients With IDH-Mutated AML Following Allogeneic Stem Cell Transplantation-A Retrospective Analysis on Behalf of the German Registry for Hematopoietic Stem Cell Transplantation and Cell Therapy, DRST
Thomas Schroeder, Sarah Flossdorf, Claudia Schuh, et al.
Page
of 24